Research collaboration announced for potential new breast cancer treatments

Inflection Biosciences and the RCSI have entered into a research collaboration aiming to understand the mechanisms of resistance to major breast cancer therapies and examine potential new treatment for patients with a cancer that is unresponsive more

24 Nov 2017 11:49 News